Alzheimer’s disease

A reliable blood test for Alzheimer’s disease – is it becoming a reality?

1024 683 Anna Stelling, PhD

The increasing number of patients suffering from dementia caused by Alzheimer’s disease (AD) is a significant challenge for society and requires action by healthcare professionals and researchers worldwide. One important…

read more

Smartphone-controlled device could revolutionise drug delivery in the brain

3450 2300 Peter Stevenson, PhD

A novel brain implant that can deliver drugs and stimulate brain cells could lead to advanced treatments for Parkinson’s, Alzheimer’s, and other brain disorders, a new study reports. The research comes…

read more

FDA issues warnings on illegal Alzheimer’s drugs

2880 1920 Peter Stevenson, PhD

On 11 February 2019, the United States Food and Drug Administration (FDA) issued warnings to 17 companies that illegally sold more than 50 products claiming to prevent, treat or cure…

read more

‘Leaky’ blood vessels linked to Alzheimer’s

3500 2333 Peter Stevenson, PhD

Leaky blood vessels in the brain appear to be a driver of cognitive dysfunction in Alzheimer’s disease, a new study reports. The research, published in Nature Medicine, followed 161 older…

read more

Herpes and Alzheimer’s: Trigger or symptom?

1920 1280 Peter Stevenson, PhD

A new review article, published in Frontiers in Aging Neuroscience, has offered fresh evidence in support of a link between the Herpes Simplex Virus 1 (HSV1) and Alzheimer’s disease (AD).…

read more

Opticians could keep a closer eye on dementia

2704 1800 Peter Stevenson, PhD

Routine retinal tests performed by opticians could help to identify those at risk of developing dementia, a new study reports. The scans – normally used to evaluate the integrity of…

read more

‘Big Bang’ of Alzheimer’s points to the origin of the disease

1600 1067 Peter Stevenson, PhD

New research has discovered the precise point at which a healthy protein becomes toxic, offering a window into the very beginnings of Alzheimer’s disease (AD). The study, led by scientists…

read more

From prognosis to prevention: Alzheimer’s biomarkers hold significant promise for the future

1200 675 Peter Stevenson, PhD

Biomarkers could change the landscape of Alzheimer’s disease (AD) forever, but we are only just scratching the surface of their potential, the audience heard during the prestigious Charles-Édouard Brown-Séquard Lecture…

read more

Preclinical Alzheimer’s unlikely to lead to dementia, new study reports

1200 829 Peter Stevenson, PhD

New data from a multi-study analysis has unveiled that preclinical Alzheimer’s disease (AD) will not lead to severe dementia in the majority of cases. The paper marks the first time…

read more
Brainwork is supported by unrestricted grants from: